Eribulin mesylate exerts antitumor effects via CD103
Eribulin mesylate (ERB) is a synthetic analog of halichondrin B, inhibiting tumor cell growth by disrupting microtubule function. Recently, anticancer drugs have been shown to not only act directly on tumor cells but also to exert antitumor effects by modifying the tumor environment. Although ERB ha...
שמור ב:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis Group
2023-12-01
|
| סדרה: | OncoImmunology |
| נושאים: | |
| גישה מקוונת: | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2218782 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
